Losartan Tablets 50mg
Treatment of essential hypertension. Treatment of kidney disease in patients with hypertension and type 2 diabetes with proteinuria >0.5 g/day as part of the antihypertensive treatment. Treatment of chronic heart failure (in patients >60 years old) when treatment with angiotensin-converting enzyme (ACE) inhibitors is not considered suitable due to incompatibility, especially cough, or contraindication. Patients with heart failure who have been stabilized with an ACE inhibitor should not switch to losartan. Patients should have a left ventricular ejection fraction <40% and should be clinically stabilized and on an established treatment regimen for heart failure. Reduction of the risk of stroke in hypertensive patients with confirmed left ventricular hypertrophy by electrocardiogram.
Pharmaceutical form
Tablet
Concentration
50mg
Combination
N/A
Disclaimer: The content of this website is for pharmaceutical industry professionals interested in creating a strategic alliance with Wexford Laboratories. This page may contain information related to health, medical conditions, physical condition and its treatment. The information contained in this site is not to diagnose a health problem and is not a substitute for the advice provided by your doctor. Always consult a doctor when in doubt about a disease and its treatment. The products are subject to the applicable patent and registration laws of each country, and may not be allowed to be registered in some markets.
